The Valley Desk

NCT00968968 · Interventional trial

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Overall registry status Terminated

Phase 3

Conditions Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov